BACKGROUND: In head and neck cancer patients prior to treatment, dysphagia noted by patients is more common than aspiration on formal swallow studies. The authors hypothesized that patient-reported dysphagia impacts multiple domains of quality of life (QOL) and predicts disease recurrence and disease-related death. METHODS: The Swal-QOL, a dysphagia-specific, swallowing-related, QOL measure, and the EuroQOL-5D-3L were administered to 159 patients before treatment with curative intent in this prospective cohort study. Logistic regression analysis evaluated associations among clinical and subjective measures. Multivariable competing risk regression tested the impact of clinical, tumor, and patient-reported measures on survival. RESULTS: Baseline dysphagia, pain, and diminished patient-reported health state were found to be closely associated with weight loss before treatment and advanced T classification. However, only 58% of patients (23 of 40 patients) reporting dysphagia experienced > 5% weight loss. Dysphagia was found to be associated with pain and/or diminished patient-reported health state, independent of weight loss. Female patients were more likely to report pain and dysphagia, whereas male patients reported dysphagia alone. Dysphagia was found to be predictive of disease recurrence and disease-related death, adjusting for T and N classifications, ECOG performance status, smoking status, and weight loss, and accounting for competing risks of death (recurrence-free survival: hazards ratio, 3.8 [95% confidence interval, 1.7-8.4; P = .001] and disease-related death: hazards ratio, 4.2 [95% confidence interval, 1.04-5; P = .004]). CONCLUSIONS: Baseline dysphagia affects multiple domains of QOL and general health perceptions in patients with head and neck cancer prior to treatment. A dysphagia measure captures the effort of maintaining nutrition, and identifies patients predisposed to disease recurrence and disease-related death.
BACKGROUND: In head and neck cancerpatients prior to treatment, dysphagia noted by patients is more common than aspiration on formal swallow studies. The authors hypothesized that patient-reported dysphagia impacts multiple domains of quality of life (QOL) and predicts disease recurrence and disease-related death. METHODS: The Swal-QOL, a dysphagia-specific, swallowing-related, QOL measure, and the EuroQOL-5D-3L were administered to 159 patients before treatment with curative intent in this prospective cohort study. Logistic regression analysis evaluated associations among clinical and subjective measures. Multivariable competing risk regression tested the impact of clinical, tumor, and patient-reported measures on survival. RESULTS: Baseline dysphagia, pain, and diminished patient-reported health state were found to be closely associated with weight loss before treatment and advanced T classification. However, only 58% of patients (23 of 40 patients) reporting dysphagia experienced > 5% weight loss. Dysphagia was found to be associated with pain and/or diminished patient-reported health state, independent of weight loss. Female patients were more likely to report pain and dysphagia, whereas male patients reported dysphagia alone. Dysphagia was found to be predictive of disease recurrence and disease-related death, adjusting for T and N classifications, ECOG performance status, smoking status, and weight loss, and accounting for competing risks of death (recurrence-free survival: hazards ratio, 3.8 [95% confidence interval, 1.7-8.4; P = .001] and disease-related death: hazards ratio, 4.2 [95% confidence interval, 1.04-5; P = .004]). CONCLUSIONS: Baseline dysphagia affects multiple domains of QOL and general health perceptions in patients with head and neck cancer prior to treatment. A dysphagia measure captures the effort of maintaining nutrition, and identifies patients predisposed to disease recurrence and disease-related death.
Authors: C A McHorney; D E Bricker; A E Kramer; J C Rosenbek; J Robbins; K A Chignell; J A Logemann; C Clarke Journal: Dysphagia Date: 2000 Impact factor: 3.438
Authors: B R Pauloski; A W Rademaker; J A Logemann; D Stein; Q Beery; L Newman; C Hanchett; S Tusant; E MacCracken Journal: Head Neck Date: 2000-08 Impact factor: 3.147
Authors: Colleen A McHorney; Joanne Robbins; Kevin Lomax; John C Rosenbek; Kimberly Chignell; Amy E Kramer; D Earl Bricker Journal: Dysphagia Date: 2002 Impact factor: 3.438
Authors: F A Pugliano; J F Piccirillo; M R Zequeira; J M Fredrickson; C A Perez; J R Simpson Journal: Otolaryngol Head Neck Surg Date: 1999-03 Impact factor: 3.497
Authors: Jonathan George; Trinitia Cannon; Victor Lai; Luther Richey; Adam Zanation; D Neil Hayes; Carol Shores; Denis Guttridge; Marion Couch Journal: Head Neck Date: 2007-05 Impact factor: 3.147
Authors: Sandra Ottosson; Ulrika Lindblom; Peter Wahlberg; Per Nilsson; Elisabeth Kjellén; Björn Zackrisson; Eva Levring Jäghagen; Göran Laurell Journal: Support Care Cancer Date: 2014-04-01 Impact factor: 3.603
Authors: Hoda Badr; Maximiliano Sobrero; Joshua Chen; Tamar Kotz; Eric Genden; Andrew G Sikora; Brett Miles Journal: Oral Oncol Date: 2019-02-11 Impact factor: 5.337
Authors: Jorine A Vermaire; Cornelis P J Raaijmakers; Evelyn M Monninkhof; C René Leemans; Robert J Baatenburg de Jong; Robert P Takes; Irma M Verdonck-de Leeuw; Femke Jansen; Johannes A Langendijk; Chris H J Terhaard; Caroline M Speksnijder Journal: Support Care Cancer Date: 2022-08-30 Impact factor: 3.359
Authors: Hans Jørgen Aarstad; Arild Andrè Østhus; Helene Hersvik Aarstad; Stein Lybak; Anne Kari H Aarstad Journal: Eur Arch Otorhinolaryngol Date: 2019-09-16 Impact factor: 2.503
Authors: Thales Salles Angelim Viana; Paulo Goberlânio de Barros Silva; Karuza Maria Alves Pereira; Mario Rogério Lima Mota; Ana Paula Negreiros Nunes Alves; Eric Fernandes de Souza; Fabricio Bitu Sousa Journal: Asian Pac J Cancer Prev Date: 2017-08-27